Latvia Vaccine Market (2025-2031) | Trends, Strategy, Outlook, Growth, Challenges, Strategic Insights, Demand, Opportunities, Forecast, Consumer Insights, Revenue, Restraints, Size, Pricing Analysis, Segmentation, Industry, Value, Segments, Share, Competitive, Supply, Companies, Analysis, Investment Trends, Drivers, Competition

Market Forecast By Type (Preventive Vaccines, Therapeutic Vaccines, DNA Vaccines), By Disease Indication (Influenza, COVID19, Hepatitis B), By Age Group (Pediatrics, Adults, Geriatrics), By Route of Administration (Intramuscular, Subcutaneous, Oral), By Technology (mRNAbased, Viral Vector, Protein Subunit) And Competitive Landscape
Product Code: ETC10939573 Publication Date: Apr 2025 Updated Date: Nov 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 65 No. of Figures: 34 No. of Tables: 19

Latvia Vaccine Market Top 5 Importing Countries and Market Competition (HHI) Analysis

In 2024, Latvia`s vaccine import market continues to be dominated by key players such as Metropolitan France, Germany, Lithuania, Poland, and the USA. Despite a high concentration with a Herfindahl-Hirschman Index (HHI) remaining very high, the market has shown significant growth with a compound annual growth rate (CAGR) of 43.42% from 2020 to 2024. However, there was a notable decline in growth rate from 2023 to 2024 at -57.01%, indicating potential shifts in the market dynamics. This data suggests a dynamic landscape in the vaccine import market in Latvia, with opportunities for further exploration and analysis.

Latvia Vaccine Market Top 5 Importing Countries and Market Competition (HHI) Analysis

Key Highlights of the Report:

  • Latvia Vaccine Market Outlook
  • Market Size of Latvia Vaccine Market,2024
  • Forecast of Latvia Vaccine Market, 2031
  • Historical Data and Forecast of Latvia Vaccine Revenues & Volume for the Period 2021-2031
  • Latvia Vaccine Market Trend Evolution
  • Latvia Vaccine Market Drivers and Challenges
  • Latvia Vaccine Price Trends
  • Latvia Vaccine Porter's Five Forces
  • Latvia Vaccine Industry Life Cycle
  • Historical Data and Forecast of Latvia Vaccine Market Revenues & Volume By Type for the Period 2021-2031
  • Historical Data and Forecast of Latvia Vaccine Market Revenues & Volume By Preventive Vaccines for the Period 2021-2031
  • Historical Data and Forecast of Latvia Vaccine Market Revenues & Volume By Therapeutic Vaccines for the Period 2021-2031
  • Historical Data and Forecast of Latvia Vaccine Market Revenues & Volume By DNA Vaccines for the Period 2021-2031
  • Historical Data and Forecast of Latvia Vaccine Market Revenues & Volume By Disease Indication for the Period 2021-2031
  • Historical Data and Forecast of Latvia Vaccine Market Revenues & Volume By Influenza for the Period 2021-2031
  • Historical Data and Forecast of Latvia Vaccine Market Revenues & Volume By COVID19 for the Period 2021-2031
  • Historical Data and Forecast of Latvia Vaccine Market Revenues & Volume By Hepatitis B for the Period 2021-2031
  • Historical Data and Forecast of Latvia Vaccine Market Revenues & Volume By Age Group for the Period 2021-2031
  • Historical Data and Forecast of Latvia Vaccine Market Revenues & Volume By Pediatrics for the Period 2021-2031
  • Historical Data and Forecast of Latvia Vaccine Market Revenues & Volume By Adults for the Period 2021-2031
  • Historical Data and Forecast of Latvia Vaccine Market Revenues & Volume By Geriatrics for the Period 2021-2031
  • Historical Data and Forecast of Latvia Vaccine Market Revenues & Volume By Route of Administration for the Period 2021-2031
  • Historical Data and Forecast of Latvia Vaccine Market Revenues & Volume By Intramuscular for the Period 2021-2031
  • Historical Data and Forecast of Latvia Vaccine Market Revenues & Volume By Subcutaneous for the Period 2021-2031
  • Historical Data and Forecast of Latvia Vaccine Market Revenues & Volume By Oral for the Period 2021-2031
  • Historical Data and Forecast of Latvia Vaccine Market Revenues & Volume By Technology for the Period 2021-2031
  • Historical Data and Forecast of Latvia Vaccine Market Revenues & Volume By mRNAbased for the Period 2021-2031
  • Historical Data and Forecast of Latvia Vaccine Market Revenues & Volume By Viral Vector for the Period 2021-2031
  • Historical Data and Forecast of Latvia Vaccine Market Revenues & Volume By Protein Subunit for the Period 2021-2031
  • Latvia Vaccine Import Export Trade Statistics
  • Market Opportunity Assessment By Type
  • Market Opportunity Assessment By Disease Indication
  • Market Opportunity Assessment By Age Group
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By Technology
  • Latvia Vaccine Top Companies Market Share
  • Latvia Vaccine Competitive Benchmarking By Technical and Operational Parameters
  • Latvia Vaccine Company Profiles
  • Latvia Vaccine Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the Latvia Vaccine Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the Latvia Vaccine Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Latvia Vaccine Market Overview

3.1 Latvia Country Macro Economic Indicators

3.2 Latvia Vaccine Market Revenues & Volume, 2021 & 2031F

3.3 Latvia Vaccine Market - Industry Life Cycle

3.4 Latvia Vaccine Market - Porter's Five Forces

3.5 Latvia Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 Latvia Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F

3.7 Latvia Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F

3.8 Latvia Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.9 Latvia Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F

4 Latvia Vaccine Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing government focus on vaccination programs to improve public health

4.2.2 Growing awareness about the importance of vaccination in preventing diseases

4.2.3 Rise in infectious diseases and outbreaks driving the demand for vaccines

4.3 Market Restraints

4.3.1 Limited access to advanced vaccines due to cost constraints

4.3.2 Vaccine hesitancy among certain population groups impacting vaccination rates

4.3.3 Regulatory challenges and approval processes delaying the introduction of new vaccines

5 Latvia Vaccine Market Trends

6 Latvia Vaccine Market, By Types

6.1 Latvia Vaccine Market, By Type

6.1.1 Overview and Analysis

6.1.2 Latvia Vaccine Market Revenues & Volume, By Type, 2021 - 2031F

6.1.3 Latvia Vaccine Market Revenues & Volume, By Preventive Vaccines, 2021 - 2031F

6.1.4 Latvia Vaccine Market Revenues & Volume, By Therapeutic Vaccines, 2021 - 2031F

6.1.5 Latvia Vaccine Market Revenues & Volume, By DNA Vaccines, 2021 - 2031F

6.2 Latvia Vaccine Market, By Disease Indication

6.2.1 Overview and Analysis

6.2.2 Latvia Vaccine Market Revenues & Volume, By Influenza, 2021 - 2031F

6.2.3 Latvia Vaccine Market Revenues & Volume, By COVID19, 2021 - 2031F

6.2.4 Latvia Vaccine Market Revenues & Volume, By Hepatitis B, 2021 - 2031F

6.3 Latvia Vaccine Market, By Age Group

6.3.1 Overview and Analysis

6.3.2 Latvia Vaccine Market Revenues & Volume, By Pediatrics, 2021 - 2031F

6.3.3 Latvia Vaccine Market Revenues & Volume, By Adults, 2021 - 2031F

6.3.4 Latvia Vaccine Market Revenues & Volume, By Geriatrics, 2021 - 2031F

6.4 Latvia Vaccine Market, By Route of Administration

6.4.1 Overview and Analysis

6.4.2 Latvia Vaccine Market Revenues & Volume, By Intramuscular, 2021 - 2031F

6.4.3 Latvia Vaccine Market Revenues & Volume, By Subcutaneous, 2021 - 2031F

6.4.4 Latvia Vaccine Market Revenues & Volume, By Oral, 2021 - 2031F

6.5 Latvia Vaccine Market, By Technology

6.5.1 Overview and Analysis

6.5.2 Latvia Vaccine Market Revenues & Volume, By mRNAbased, 2021 - 2031F

6.5.3 Latvia Vaccine Market Revenues & Volume, By Viral Vector, 2021 - 2031F

6.5.4 Latvia Vaccine Market Revenues & Volume, By Protein Subunit, 2021 - 2031F

7 Latvia Vaccine Market Import-Export Trade Statistics

7.1 Latvia Vaccine Market Export to Major Countries

7.2 Latvia Vaccine Market Imports from Major Countries

8 Latvia Vaccine Market Key Performance Indicators

8.1 Immunization coverage rates among different age groups

8.2 Number of government-funded vaccination campaigns conducted annually

8.3 Research and development investment in new vaccine technologies and formulations

8.4 Rate of vaccine uptake in high-risk populations

8.5 Number of reported cases of vaccine-preventable diseases

9 Latvia Vaccine Market - Opportunity Assessment

9.1 Latvia Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 Latvia Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F

9.3 Latvia Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F

9.4 Latvia Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.5 Latvia Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F

10 Latvia Vaccine Market - Competitive Landscape

10.1 Latvia Vaccine Market Revenue Share, By Companies, 2024

10.2 Latvia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Latest Reports

Industry Events and Analyst Meet

Whitepaper

Read All
Chat With 6W AI Intelligence